Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
AVTE - Aerovate Therapeutics, Inc.
Market Cap 456.25M P/E - EPS this Y 3.10% Ern Qtrly Grth -
Income -87.94M Forward P/E -6.31 EPS next Y 64.00% 50D Avg Chg -2.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -20.00%
Dividend N/A Price/Book 3.63 EPS next 5Y - 52W High Chg -46.00%
Recommedations 3.00 Quick Ratio 6.12 Shares Outstanding 28.87M 52W Low Chg 20.00%
Insider Own 0.02% ROA -44.04% Shares Float 11.85M Beta 1.03
Inst Own 100.84% ROE -74.42% Shares Shorted/Prior 1.07M/1.16M Price 16.53
Gross Margin - Profit Margin - Avg. Volume 82,645 Target Price 2.33
Oper. Margin - Earnings Date Aug 12 Volume 152,546 Change -1.43%
Healthcare | Biotechnology | United States
About Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Aerovate Therapeutics, Inc. News
10/31/24 Jade, another biotech spinout of Paragon, to merge with Aerovate
10/31/24 Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement
07/08/24 Aerovate Therapeutics to Explore Strategic Alternatives
07/08/24 Ligand to buy Apeiron; Roche reports another TIGIT setback
07/02/24 Aerovate slashes workforce after failed Phase IIb trial
06/27/24 The 3 Hottest Stock Downgrades From Last Week
06/18/24 Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals
06/17/24 Why 93% Of Aerovate Therapeutics' Value Just Went Up In Smoke
06/17/24 Top Midday Decliners
06/17/24 Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
06/06/24 Here's Why We're Watching Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Situation
05/21/24 Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference
05/13/24 Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
04/04/24 Aerovate Therapeutics Inc CEO Timothy Noyes Sells 10,000 Shares
03/27/24 Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
03/26/24 Aerovate Therapeutics Inc (AVTE) Reports Increased R&D Expenses and Net Loss in 2023
03/25/24 Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
03/21/24 Chief Medical Officer Hunter Gillies Sells 7,000 Shares of Aerovate Therapeutics Inc (AVTE)
03/21/24 Insider Sell: Aerovate Therapeutics Inc's (AVTE) Chief Technical Officer Marinus Verwijs Sells ...
03/06/24 Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Jan 17 Sell 19.5 4,000 78,000 3,251 01/19/24
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Jan 17 Option 1.74 4,000 6,960 7,251 01/19/24
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Jan 05 Sell 19.12 4,600 87,952 1,609 01/08/24
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Jan 05 Option 1.94 4,600 8,924 6,209 01/08/24
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Dec 27 Sell 24.5 125 3,062 3,251 12/29/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Dec 27 Option 2.14 125 268 3,376 12/29/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Dec 20 Sell 19.5 4,000 78,000 3,251 12/22/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Dec 20 Option 1.74 4,000 6,960 7,251 12/22/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Dec 13 Sell 19.5 12,000 234,000 3,251 12/15/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Dec 13 Option 1.74 12,000 20,880 13,148 12/15/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Dec 05 Sell 16.3 4,600 74,980 1,609 12/07/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Dec 05 Option 1.94 4,600 8,924 6,209 12/07/23
Dake Benjamin T SEE REMARKS SEE REMARKS Dec 06 Sell 16.11 10,283 165,659 1,291 12/07/23
Dake Benjamin T SEE REMARKS SEE REMARKS Dec 06 Option 1.94 10,283 19,949 11,574 12/07/23
Dake Benjamin T SEE REMARKS SEE REMARKS Nov 27 Sell 16.24 12,517 203,276 1,291 11/29/23
Dake Benjamin T SEE REMARKS SEE REMARKS Nov 27 Option 1.94 12,517 24,283 13,808 11/29/23
Dake Benjamin T SEE REMARKS SEE REMARKS Nov 22 Sell 15.66 14,372 225,066 1,291 11/27/23
Dake Benjamin T SEE REMARKS SEE REMARKS Nov 22 Option 2.01 14,372 28,888 6,281 11/27/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Nov 22 Sell 15 13,800 207,000 1,609 11/27/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Nov 22 Option 1.94 13,800 26,772 15,409 11/27/23
Verwijs Marinus CHIEF TECHNOLOGY OFF.. CHIEF TECHNOLOGY OFFICER Nov 01 Sell 10.4625 970 10,149 11/03/23
NOYES TIMOTHY P CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Nov 01 Sell 10.42 1,092 11,379 11/03/23
Dake Benjamin T SEE REMARKS SEE REMARKS Sep 06 Sell 15.03 3,961 59,534 1,291 09/08/23
Dake Benjamin T SEE REMARKS SEE REMARKS Sep 06 Option 2.01 3,961 7,962 1,321 09/08/23
Dake Benjamin T SEE REMARKS SEE REMARKS Aug 07 Option 1.94 10,283 19,949 11,574 08/09/23
Dake Benjamin T SEE REMARKS SEE REMARKS Aug 07 Sell 15.86 10,283 163,088 1,291 08/09/23
NOYES TIMOTHY P CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jul 17 Sell 18.11 4,522 81,893 07/19/23
NOYES TIMOTHY P CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jul 17 Option 2.14 4,522 9,677 4,522 07/19/23
Dake Benjamin T SEE REMARKS SEE REMARKS Jul 06 Sell 16.66 10,283 171,315 1,291 07/07/23
Dake Benjamin T SEE REMARKS SEE REMARKS Jul 06 Option 1.94 10,283 19,949 11,574 07/07/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Jul 05 Sell 17.55 2,250 39,488 1,609 07/07/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Jul 05 Option 1.94 2,250 4,365 3,859 07/07/23
Dake Benjamin T SEE REMARKS SEE REMARKS Jun 06 Sell 16.63 10,283 171,006 1,291 06/08/23
Dake Benjamin T SEE REMARKS SEE REMARKS Jun 06 Option 1.94 10,283 19,949 11,574 06/08/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Jun 05 Sell 16.26 2,250 36,585 1,609 06/07/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Jun 05 Option 1.94 2,250 4,365 3,859 06/07/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER May 19 Option 1.74 65 113 3,316 05/23/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER May 19 Sell 19.5 65 1,268 3,251 05/23/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER May 17 Sell 19.59 1,090 21,353 3,251 05/19/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER May 17 Option 1.74 1,090 1,897 4,341 05/19/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER May 05 Sell 21.21 2,250 47,722 1,609 05/09/23
NIVEN RALPH CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER May 05 Option 1.94 2,250 4,365 3,859 05/09/23
Dake Benjamin T SEE REMARKS SEE REMARKS May 08 Sell 22.18 10,284 228,099 1,291 05/09/23
Dake Benjamin T SEE REMARKS SEE REMARKS May 08 Option 1.94 10,284 19,951 11,575 05/09/23
Verwijs Marinus SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT, CMC May 03 Sell 20.7897 759 15,779 05/05/23
NOYES TIMOTHY P CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER May 01 Sell 20.88 15,693 327,670 05/03/23
NOYES TIMOTHY P CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER May 01 Option 2.14 15,000 32,100 15,693 05/03/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Apr 21 Sell 19.5 4,000 78,000 1,960 04/25/23
Gillies Hunter CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Apr 21 Option 1.74 4,000 6,960 5,960 04/25/23
Dake Benjamin T SEE REMARKS SEE REMARKS Apr 06 Sell 18.17 10,283 186,842 04/07/23